

Opioid Use Disorder (OUD) is a complex and chronic brain disease characterized by the compulsive use of opioids, despite the detrimental consequences it brings to an individual's health, social life, and overall functioning. It is a condition that transcends physical dependence, embodying a pattern of behavior where the pursuit and consumption of opioids dominate an individual’s life.
OUD is not merely a physical dependence on opioids but a multifaceted disorder involving changes in the brain and behavior. The hallmark of this disorder is the persistent use of opioids, driven by changes in the brain's reward and regulatory systems, often leading to harmful outcomes. Individuals with OUD may experience intense cravings and find it challenging to control their opioid use, even when they are aware of the negative impacts.
OUD represents a significant public health challenge, with millions affected globally. In the United States alone, recent data suggests that 1.6 million people were diagnosed with OUD in 2019, highlighting the pervasive nature of this crisis. Tragically, 68,630 opioid-overdose related deaths were reported nationally in 2020, with 80,411 reported in 2021, averaging around 220 deaths per day, a stark reminder of the disorder's severity and the urgency of addressing it.
The repercussions of OUD extend beyond the individual. It disrupts relationships, hinders performance in work or educational settings, and often results in legal and financial troubles. This broader impact underscores the need for a comprehensive approach to prevention, treatment, and support for those affected and their communities.
Despite its challenges, OUD is treatable. A combination of medication and behavioral therapies has proven effective in helping individuals overcome opioid dependence. Treatments are designed not just to stop opioid use but also to support long-term recovery and improve quality of life. With the right intervention and support, individuals with OUD can embark on a journey to recovery and regain control over their lives.
Understanding OUD as a chronic brain disease necessitates a shift in perspective. It calls for compassionate care and a nuanced understanding of the disorder's nature. This approach not only helps in treating individuals effectively but also plays a crucial role in reducing the stigma associated with OUD, thus encouraging more people to seek help.
Opioids are a class of drugs renowned for their pain-relieving properties, derived from the opium poppy plant or synthesized in laboratories. They play a crucial role in medical practice, primarily used for pain management but also in treating coughs and diarrhea. However, their potent effects on the brain make them susceptible to misuse, leading to the risk of addiction, known as Opioid Use Disorder (OUD).
Opioids are a diverse group of substances known for their potent pain-relieving properties. They are categorized based on their origin—natural, semi-synthetic, and synthetic. Each type has unique characteristics and uses in medical practice. Here's a closer look at the different types of opioids:
Derived directly from the opium poppy plant, natural opiates are among the oldest pain relievers known to humanity. Common natural opiates include:
These are created in labs from natural opiates and are designed to provide pain relief with varying strengths and durations. Examples include:
These opioids are completely synthesized in labs and include some of the most potent painkillers used in medicine.
Opioids exert their effect by binding to specific receptors in the brain, spinal cord, and other areas of the body. They block pain signals sent from the body through the spinal cord to the brain. This action not only diminishes the perception of pain but also can induce feelings of relaxation and euphoria.
The euphoric effects of opioids are due to their impact on the brain's reward system. They trigger the release of dopamine, a neurotransmitter associated with pleasure and satisfaction. This activation of the reward pathway can make opioids highly addictive for some individuals as the brain begins to associate opioid use with positive reinforcement.
With prolonged use, individuals may develop tolerance, necessitating higher doses to achieve the same pain relief or euphoric effect. This escalation can lead to physical dependence, where the body adapts to the drug's presence. If opioid use is reduced or stopped, withdrawal symptoms often occur, which can be physically and emotionally distressing, further complicating the cycle of addiction.
It's important to note that physical dependence on opioids, characterized by tolerance and withdrawal, is not synonymous with OUD. OUD involves a more complex pattern of behavior, where the pursuit and consumption of opioids negatively impact an individual's health and daily life.
The opioid crisis is a critical public health issue that has escalated into an epidemic, deeply affecting communities across the globe, particularly in the United States. It is characterized by widespread misuse of both prescription and non-prescription opioids, leading to a dramatic increase in opioid-related overdoses and deaths.
Opioid Use Disorder (OUD) is a medical condition characterized by an impaired ability to stop or control opioid use despite the negative impact it has on one's life. It encompasses a range of behaviors, from misuse of prescribed opioids to dependency on illicit drugs like heroin.
The diagnosis of OUD is based on criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). A diagnosis is considered when at least two of the following symptoms occur within a 12-month period:
The severity of OUD is gauged based on the number of criteria present:
Tolerance refers to needing higher doses of opioids to achieve the same effect or feeling less effect with the same dose over time. Conversely, withdrawal symptoms may include nausea, muscle aching, fever, diarrhea, and insomnia, reflecting the body's physical dependence on the substance.
It's important to distinguish OUD from physical dependence. Physical dependence on opioids can occur with long-term use, even if the medication is taken as prescribed. However, it doesn't necessarily mean that a person has OUD, which involves a pattern of compulsive use and a range of harmful consequences.
Opioid Use Disorder (OUD) does not arise from a single cause but is the result of a complex interplay of various factors. Understanding these risk factors can help in early identification and prevention efforts.
Genetic and biological factors play a significant role in the development of OUD. These include inherited traits and individual differences in brain chemistry that can influence how a person reacts to opioids.
The environment in which an individual lives and the social interactions they have can significantly impact the likelihood of developing OUD. These factors often shape attitudes and behaviors toward drug use.
Mental health and emotional well-being are deeply intertwined with the risk of developing OUD. Psychological factors can both predispose individuals to addiction and result from the challenges of managing chronic pain or mental health conditions.
Medical history, especially related to pain management, and the way opioids are prescribed play a significant role in the risk of developing OUD. This includes both the length of time and the dosage of opioid prescriptions.
Individual behavior and lifestyle choices can also influence the risk of developing OUD. This includes patterns of behavior that may predispose an individual to substance misuse.
Opioid Withdrawal Syndrome is a significant and challenging aspect of Opioid Use Disorder (OUD). It occurs when a person who has become physically dependent on opioids either reduces their opioid use or stops taking them altogether. Understanding the symptoms and management of opioid withdrawal is crucial for both individuals undergoing withdrawal and healthcare providers managing their treatment.
Opioid Withdrawal Syndrome is the body's response to the absence of opioids after a period of regular use. This response is due to physical dependence, where the body adapts to the presence of opioids and experiences a range of symptoms when the opioids are no longer present.
Opioid withdrawal symptoms can range from mild to severe, depending on factors such as the duration of opioid use, the type of opioid used, and the individual’s physical health. Symptoms typically begin within a few hours to a few days after discontinuing or reducing opioid use and include:
The experience of opioid withdrawal can vary significantly from person to person, and the timeline is influenced by factors such as the specific opioid used, the duration and intensity of use, individual physiology, and overall health. It is important to note that withdrawal timelines can change.
The induction process into treatment can range from 24 hours to more. Some people are candidates for low-dose induction, and some for high-dose induction. Again, this is dependent on the person and the substance they are using. Here is a general outline of the typical timeline for opioid withdrawal:
Due to the intense nature of some withdrawal symptoms and the potential for complications, medically supervised withdrawal (detoxification) is highly recommended. Supervision ensures that individuals are safe, their symptoms are managed effectively, and they have support through the psychological aspects of withdrawal.
Medical supervision also paves the way for a smoother transition into long-term treatment and recovery programs, which are crucial for sustainable recovery from OUD.
The treatment and management of Opioid Use Disorder (OUD) are multifaceted, involving a combination of medication, behavioral therapy, and continuous care. Successful treatment typically requires a personalized approach, addressing not only the addiction itself but also any associated psychological, social, and health issues.
Medications for Addiction Treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies to treat OUD. These medications help alleviate withdrawal symptoms and reduce cravings, making it easier for patients to engage in therapy and recovery.
Behavioral therapies are key components of OUD treatment, focusing on changing drug use behaviors through counseling and other therapy techniques. These approaches help patients develop skills to manage their addiction and modify attitudes and behaviors related to drug abuse.
Supportive care and recovery services are vital in providing the necessary social and emotional support. These services promote long-term recovery and help individuals reintegrate into their communities successfully.
Long-term management of OUD involves ongoing care and support. It focuses on maintaining abstinence, preventing relapse, and sustaining the recovery journey over a lifetime.
A holistic approach to OUD treatment recognizes the importance of treating the whole person, not just the addiction. It includes strategies to improve overall health and well-being.
Treating Opioid Use Disorder (OUD) effectively often requires adapting to the unique circumstances and needs of different patient groups. These special considerations are essential to provide personalized and effective care.
Treating OUD in pregnant women demands a careful balance between managing the disorder and ensuring the safety of both the mother and the developing fetus. This includes choosing appropriate medications and monitoring for complications.
Individuals with OUD often face co-occurring mental health disorders, necessitating an integrated approach to treatment that addresses both sets of conditions in a coordinated manner.
Young individuals with OUD require specialized treatment approaches that are tailored to their age and developmental stage, often involving family support and engagement.
For patients with chronic pain who have a history of OUD, treatment strategies must prioritize effective pain management while minimizing the risk of relapse into opioid misuse.
Treating patients with poly-substance use involves a comprehensive approach that addresses all aspects of their substance use to ensure a holistic recovery.
A patient's cultural background and social circumstances play a significant role in treatment outcomes, requiring culturally sensitive and socially informed treatment approaches.
Supporting a loved one who is struggling with Opioid Use Disorder (OUD) can be a challenging yet crucial part of their journey to recovery. The first step in providing effective support is recognizing the signs of opioid misuse, which may include behavioral changes, social withdrawal, neglect of responsibilities, or physical symptoms like drowsiness or altered sleep patterns. It's also important to be alert to mood shifts, health issues, financial troubles, or legal complications that might signal a problem with opioid use.
When approaching a loved one about their opioid use, it's essential to communicate openly and compassionately. Initiating a non-confrontational conversation and expressing your concerns without judgment or blame can encourage them to open up about their struggles. At the same time, educating yourself about OUD is vital. Understanding the disorder, its symptoms, and treatment options allows you to provide informed support and be aware of various recovery programs, including Medications for Addiction Treatment (MAT), counseling, and support groups.
Encouraging your loved one to seek professional help is a critical step. Offer your assistance in researching treatment options and facilitate making appointments or providing transportation if necessary. Emotional and practical support is also incredibly valuable. Being there to listen, offering encouragement, and assisting with practical needs such as childcare or transportation can significantly alleviate the burden on someone grappling with OUD.
Setting healthy boundaries is essential for both your well-being and that of your loved one. Clearly communicate behaviors you cannot tolerate and ensure you take care of your own mental and emotional health, perhaps by seeking support for yourself through counseling or support groups. Recovery is a long-term process and may include setbacks. Being patient and understanding, staying informed about their recovery process, and offering ongoing support are key to helping your loved one navigate this journey.
It's crucial to understand that relapse can be part of the recovery process and does not signify failure. If a relapse occurs, encourage your loved one to continue their treatment and remind them that recovery is still within reach. Your support can make a significant difference in their journey towards overcoming OUD.
For those grappling with Opioid Use Disorder (OUD), finding the right support and treatment is crucial for the journey towards recovery. Porch Light Health stands out as a beacon of hope and assistance in this challenging journey. With over 60 care locations spread throughout Colorado and New Mexico, Porch Light Health offers comprehensive care and support to individuals struggling with OUD.
Porch Light Health specializes in providing Medications for Addiction Treatment (MAT), an evidence-based approach that combines medication with counseling and behavioral therapies to treat substance use disorders. This integrative treatment model is designed to address the whole person, not just the addiction, ensuring a more sustainable path to recovery.
In addition to MAT, Porch Light Health offers a range of behavioral and psychiatric care services. Understanding that OUD often coexists with other mental health issues, the clinic's approach to care includes addressing these co-occurring disorders. This holistic treatment strategy enhances the effectiveness of OUD treatment and supports overall mental and emotional well-being.
Porch Light Health is committed to offering accessible, compassionate, and personalized care. Our team of dedicated professionals understands the complexities of OUD and works closely with each individual to develop a tailored treatment plan that meets their specific needs.
If you or a loved one is struggling with Opioid Use Disorder, Porch Light Health is here to help. Reach out to take the first step towards recovery and healing. Their extensive network of care locations and comprehensive treatment options provide a solid foundation for overcoming addiction and reclaiming control of your life. Register as a new patient today.
Opioid use disorder. (n.d.). https://www.psychiatry.org/patients-families/opioid-use-disorder
SAMHSA, Center for Behavioral Health Statistics and Quality. (n.d.). Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR090120.htm
Drug overdose death rates | National Institute on Drug Abuse. (2023, September 25). National Institute on Drug Abuse. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
Opioid Use Disorder: Preventing and treating | Healthcare professionals | Opioids | CDC. (n.d.). https://www.cdc.gov/opioids/healthcare-professionals/prescribing/opioid-use-disorder.html
National Library of Medicine. (n.d.). Opioids and Opioid Use Disorder (OUD). https://medlineplus.gov/opioidsandopioidusedisorderoud.html
Mind matters: The body’s response to opioids | National Institute on Drug Abuse. (2022, June 13). National Institute on Drug Abuse. https://nida.nih.gov/research-topics/parents-educators/lesson-plans/mind-matters/opioids
Kosten, T. R., & George, T. P. (2002). The Neurobiology of Opioid dependence: Implications for treatment. Science & Practice Perspectives, 1(1), 13–20. https://doi.org/10.1151/spp021113
Understanding the opioid overdose epidemic | Opioids | CDC. (n.d.). https://www.cdc.gov/opioids/basics/epidemic.html
Opioid crisis: Status of public health emergency authorities. (n.d.). U.S. GAO. https://www.gao.gov/products/gao-18-685r
Hirsch, R. (2017, April 1). The opioid epidemic: It’s time to place blame where it belongs. PubMed Central (PMC). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140023/
Fentanyl | Opioids | CDC. (n.d.). https://www.cdc.gov/opioids/basics/fentanyl.html
Walden University. (2022, October 22). Opioid crisis: the strain it places on the healthcare system. Walden University. https://www.waldenu.edu/online-masters-programs/master-of-healthcare-administration/resource/opioid-crisis-the-strain-it-places-on-the-healthcare-system
Assistant Secretary for Public Affairs (ASPA). (2022, November 29). Harm reduction. Overdose Prevention Strategy. https://www.hhs.gov/overdose-prevention/harm-reduction
IT Matters Colorado | DSM-5 Criteria for Diagnosis of Opioid Use Disorder. https://www.asam.org/docs/default-source/education-docs/dsm-5-dx-oud-8-28-2017.pdf
Berrettini, W. H. (2017). A brief review of the genetics and pharmacogenetics of opioid use disorders. Dialogues in Clinical Neuroscience, 19(3), 229–236. https://doi.org/10.31887/dcns.2017.19.3/wberrettini
Kosten, T. R., & George, T. P. (2002). The Neurobiology of Opioid dependence: Implications for treatment. Science & Practice Perspectives, 1(1), 13–20. https://doi.org/10.1151/spp021113
Mennis, J., Stahler, G. J., & Mason, M. (2016). Risky Substance Use Environments and Addiction: A New Frontier for Environmental Justice research. International Journal of Environmental Research and Public Health, 13(6), 607. https://doi.org/10.3390/ijerph13060607
Opioid Use Among Individuals with Posttraumatic Stress Disorder. PTSD Research Quarterly. National Center for PTSD. Vol. 30/No. 1. 2019. https://www.ptsd.va.gov/publications/rq_docs/V30N1.pdf
Santo, T., Campbell, G., Gisev, N., & Degenhardt, L. (2022). Exposure to childhood trauma increases risk of opioid use disorder among people prescribed opioids for chronic non-cancer pain. Drug and Alcohol Dependence, 230, 109199. https://doi.org/10.1016/j.drugalcdep.2021.109199
Volkow, N. D., & McLellan, A. T. (2016). Opioid abuse in chronic pain — Misconceptions and mitigation strategies. The New England Journal of Medicine, 374(13), 1253–1263. https://doi.org/10.1056/nejmra1507771
Shah, M. (2023, July 21). Opioid withdrawal. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK526012/
Case-Lo, C. (2023, November 27). Withdrawing from Opiates and Opioids. Healthline. https://www.healthline.com/health/opiate-withdrawal
Katie E. Golden, MD. (2023). GoodRX - Opioid Withdrawal: Typical Timeline and Common Symptoms (n.d.-b). https://www.goodrx.com/conditions/opioid-use-disorder/how-long-opioid-withdrawal-symptoms-last
Post-Acute Withdrawal Syndrome (PAWS) | Semel Institute for Neuroscience and Human Behavior. (n.d.). https://www.semel.ucla.edu/dual-diagnosis-program/News_and_Resources/PAWS
Methadone. (2023, September 18). https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/methadone
Buprenorphine. (2023, September 18). https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/buprenorphine
Naltrexone. (2023, September 18). https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/naltrexone
Carley, J. A., & Oesterle, T. (2021). Therapeutic Approaches to Opioid Use Disorder: What is the Current Standard of Care? International Journal of General Medicine, Volume 14, 2305–2311. https://doi.org/10.2147/ijgm.s295461
Guenzel, N. (2023, July 21). Addiction relapse prevention. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK551500/
Dey, S. (2023, July 21). Alternatives to opioids for managing pain. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK574543/
Opioid Use Disorder and Pregnancy | CDC. (2022, November 15). Centers for Disease Control and Prevention. https://www.cdc.gov/pregnancy/opioids/treatment.html
Weller, A. E., Crist, R. C., Reiner, B. C., Doyle, G. A., & Berrettini, W. H. (2020). Neonatal Opioid Withdrawal Syndrome (NOWS): a transgenerational echo of the opioid crisis. Cold Spring Harbor Perspectives in Medicine, 11(3), a039669. https://doi.org/10.1101/cshperspect.a039669
Jones, C. M., & McCance‐Katz, E. F. (2019). Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence, 197, 78–82. https://doi.org/10.1016/j.drugalcdep.2018.12.030
St Marie, B., & Broglio, K. (2020). Managing pain in the setting of opioid use disorder. Pain Management Nursing, 21(1), 26–34. https://doi.org/10.1016/j.pmn.2019.08.003
Polysubstance use facts. (n.d.). https://www.cdc.gov/stopoverdose/polysubstance-use/index.html